World Congress: Drug Modality Game Changers

In the race to the clinic, disruptors are taking the lead. We are equipped to help you navigate challenges along your drug discovery and development journey.

Watch the videos

Terry Pirovolakis standing on stage.

Charles River’s sixth World Congress, “Drug Modalities Game Changers,” is part of our ongoing efforts to progress and raise awareness about how advanced modalities are disrupting drug development. This one-day global event took place in Cambridge, MA with sessions streamed live to the Cambridge, UK and San Francisco, CA satellite locations. This year's World Congress showcased how advanced modalities are shaping drug development through presentations from scientific distributors, panel discussions, and patient success stories. In case you missed it, the presentations are available for viewing below.

  Welcome and Opening Remarks
  Charles River World Congress Researcher Award
  Small Molecule Sequestrants
  AI and Digital Twins to Drive the Next Generation Drug Discovery and Development
  Impact of Phosphoryl Guanidine on Oligonucleotide Pharmacology in Preclinical and Clinical Studies
  Charles River World Congress Researcher Award Reunion Panel
  Development of Therapeutic Antibodies
  Emily Whitehead's Journey to CAR T

 

We are equipped to help you navigate challenges along your drug discovery journey.

Begin Your Journey

Terry Pirovolakis Headshot

Terry Pirovolakis
Founder of CureSPG50 


Tom Whitehead Headshot

Tom Whitehead
Co-Founder Emily Whitehead Foundation 


Julie Frearson Headshot

Julie Frearson
SVP Chief Scientific Officer
Charles River


Sonia Vallabh Headshot

Sonia Vallabh
Associated Scientist
Broad Institute


Eric Minikel Headshot

Eric Minikel
Associated Scientist
Broad Institute


David Hysong Headshot

David Hysong
Patient, Founder & Chief Executive Officer
SHEPHERD Therapeutics


Rich Horgan Headshot

Rich Horgan
Founder and CEO
Cure Rare Disease


Matthew Porteus Headshot

Matthew Porteus
Professor of Definitive and Curative Medicine at Stanford University, Scientific founder of CRISPR T
Stanford University


Mike Byrne Headshot

Mike Byrne
Vice President, In Vivo and CNS Biology
Wave Life Sciences


Victor Goldmacher Headshot

Victor S. Goldmacher
Co-founder and Chief Scientific Officer
ImmuVia


Colby Souders Headshot

Colby Souders
Chief Scientific Officer
BrickBio


Colin Hill Headshot

Colin Hill
CEO
Aitia


Becky Schweighardt Headshot

Becky Schweighardt
Chief Scientific Officer
Grace Science


Shekar Shetty Headshot

Shekar Shetty
Chief Executive Officer
Clear Scientific


Piercen Oliver Headshot

Piercen Oliver
VP Research & Development
Clear Scientific


Sam Chuang Headshot

Sam Chuang
Director, Scientific Advisory Services
Charles River


Birgit Girshick Headshot

Birgit Girshick
EVP Chief Operating Officer
Charles River